| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.4 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |